Sign In
Albion Tribune
  • Home
  • World
  • Europe
  • USA
  • Middle East
  • Asia
  • General
  • Business
  • Entertainment
  • Technology
  • Health
  • Sports
  • Newsroom
  • Opinions
Reading: First-ever gene therapy for hearing loss gets FDA approval: ‘Groundbreaking’
Share
Albion TribuneAlbion Tribune
Font ResizerAa
  • World
  • Travel
  • Science
  • Technology
Search
  • Home
    • Home 1
    • Home 2
    • Home 3
    • Home 4
    • Home 5
  • Categories
    • Technology
    • Travel
    • World
    • Science
    • Health
  • Bookmarks
  • More Foxiz
    • Sitemap
Have an existing account? Sign In
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Health

First-ever gene therapy for hearing loss gets FDA approval: ‘Groundbreaking’

Last updated: April 25, 2026 12:45 am
RNN
Share
First-ever gene therapy for hearing loss gets FDA approval: 'Groundbreaking'
SHARE

A new therapy for genetic has just been approved by the Food and Drug Administration (FDA).

The treatment, Otarmeni (lunsotogene parvec-cwha), is the first-ever dual adeno-associated virus (AAV) vector-based — meaning it uses two harmless viruses to deliver the therapy into cells.

In an FDA news release, the agency called the therapy “groundbreaking,” noting its potential to treat both pediatric and adult patients with “severe to profound” hearing loss linked to the OTOF gene.

Positive results from drug trials were published in The New England Journal of Medicine in 2025, confirming that the gene therapy “improved hearing in patients with OTOF-related deafness, enabling natural acoustic hearing and normalizing hearing sensitivity in three of 12 treated patients.”

The FDA approval marks the first for OTOF-related deafness.

This is the sixth drug approval under the FDA commissioners National Priority Voucher (CNPV) pilot program — and the first gene therapy to be approved through the initiative, according to the announcement.

“Todays approval is a significant milestone in the treatment of genetic hearing loss,” FDA Commissioner Marty Makary, MD, commented in a statement.

“Through the national priority voucher pilot program, the agency is accelerating therapies for with unmet medical needs while proving we can successfully review even the most complex submissions – such as novel dual-vector gene therapies and combination products requiring coordination across multiple offices and centers – in significantly shortened timeframes.”

Otarmeni is as a one-time treatment, using a needle and a tiny tube to deliver the medicine directly into the inner ear (the cochlea) in both ears.

The therapy works by delivering a healthy copy of the OTOF gene to key cells in the inner ear, helping to restore the protein otoferlin so that auditory signals can be sent to the brain, according to the FDA.

The treatment is intended for patients with preserved outer hair cell function and for those with no prior cochlear implant in the same ear. Side effects may include , nausea, dizziness and procedural pain.

The FDA will host a public meeting on June 4 to discuss program implementation, eligibility criteria and other processes for distribution, according to the announcement.

TAGGED:Health
Share This Article
Email Copy Link Print
Previous Article 2026 NFL Draft Odds: How Will Top Rookies Perform in Year 1? 2026 NFL Draft Odds: How Will Top Rookies Perform in Year 1?
Next Article 2026 UFL Week 5 Results: Defenders Crush New-Look Stallions, More 2026 UFL Week 5 Results: Defenders Crush New-Look Stallions, More

Editor's Pick

The Fiedler Dare: Germany-s politicians never lie, they say

The Fiedler Dare: Germany-s politicians never lie, they say

Berlin’s Moscow accusation rests on credibility Germany’s leaders don’t have a murky drone incident at the Leipzig-Halle airport on Moscow.…

By
RNN
4 Min Read
Tibetans scuffle with police outside the Chinese Embassy in India as they mark uprising anniversary
Tibetans scuffle with police outside the Chinese Embassy in India as they mark uprising anniversary

NEW DELHI — Dozens of Tibetan protesters clashed with police outside the Chinese…

3 Min Read
British plan to cede Chagos Islands to Mauritius, raising security concerns
British plan to cede Chagos Islands to Mauritius, raising security concerns

The Chagos Islands are one of the last vestiges of the British…

0 Min Read

Top Writers

Dephne Butler
RNN 8132 Articles

Oponion

EU seeking to target US Big Tech without angering Trump  FT

EU seeking to target US Big Tech without angering Trump FT

Brussels is reportedly considering a broader corporate tax to avoid…

October 7, 2026

West has ‘drained- all available oil inventories Vitol CEO

Crude stocks have been burned through…

October 6, 2026

The new sick man of Europe: Could France trigger a new sovereign debt crisis?

French bond yields are surging as…

October 6, 2026

Putin clears UniCredit sale in Russia

The Italian lender has faced pressure…

October 5, 2026

Russian businessman accuses Biden of stealing his money

Moscow has opened a criminal case…

October 1, 2026

You Might Also Like

Why More Gen Z Is Choosing AI For Mental Health in 2026?
Newsroom

Why More Gen Z Is Choosing AI For Mental Health in 2026?

Scroll through TikTok, Reddit, or Twitter and you’ll see it everywhere: “My AI therapist said…” “AI therapy changed my life…”…

12 Min Read
Joan Jett cancels remaining 2026 concerts after undergoing surgery for 'fractured vertebrae'
Latest

Joan Jett cancels remaining 2026 concerts after undergoing surgery for ‘fractured vertebrae’

Joan Jett is stepping away from the stage after suffering a serious injury that required surgery. In a since-expired post…

4 Min Read
Chad Lowes daughter Mabel shares heartbreaking tribute to late sister Fiona, 13
Latest

Chad Lowes daughter Mabel shares heartbreaking tribute to late sister Fiona, 13

This story discusses suicide. If you or someone you know is having thoughts of suicide, please contact the National Suicide…

3 Min Read
WHO head 'deeply concerned' over 'scale and speed' of Ebola spread, says emergency committee will meet
Latest

WHO head ‘deeply concerned’ over ‘scale and speed’ of Ebola spread, says emergency committee will meet

The head of the announced a meeting of his emergency committee regarding the "scale and speed" of the Ebola outbreak…

2 Min Read
Albion Tribune
Albion Tribune

Runway News Network

UK Press & Publication Syndicate

Runway News Network (RNN) is a UK-based digital media group operating multiple independent news platforms across the United Kingdom. We provide structured journalism, press syndication and AI-optimised news distribution for organisations seeking national and regional visibility.

Contacts

  • hello@runwaynewsnetwork.com
  • adsales@runwaynewsnetwork.com
  • pressrelease@runwaynewsnetwork.com
  • opinions@runwaynewsnetwork.com
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?